Develops a scar management solution using patches embedded with dissolvable micro-tips that deliver RNA-based therapeutics to reduce scar volume and improve texture. Clinical studies show a 95% reduction in scar volume after 60 days, outperforming traditional silicone gel sheets in both effectiveness and patient preference.
Funding
Funding not disclosed
Founders
Product
Problem
Existing scar treatments often show limited effectiveness, require invasive procedures, or cause adverse side effects, leading to patient dissatisfaction. Traditional options like silicone sheets can be cumbersome to use and yield inconsistent results in reducing scar volume and improving texture.
Solution
BioRNA Antiscar offers a scar management solution using patches embedded with dissolvable micro-tips that deliver RNA-based therapeutics directly into the scar tissue. These micro-tips painlessly penetrate the skin, releasing RNA molecules that target the root causes of scar formation, reducing scar volume and improving overall appearance. Clinical studies demonstrate a significant reduction in scar volume and a high rate of patient preference compared to traditional silicone gel sheets. The patches are designed for easy, at-home application, providing a non-invasive and steroid-free alternative for scar management.
Target Audience
The primary target audience includes individuals with newly formed or established scars resulting from surgery, injuries, burns, or acne, as well as clinicians seeking advanced scar management solutions for their patients.
Features
- Dissolvable micro-tips for targeted delivery of RNA-based therapeutics
- RNA molecules designed to modulate collagen production and reduce scar tissue formation
- Non-invasive, painless application via adhesive patch
- Clinically proven to reduce scar volume by up to 95% in 60 days
- Higher patient preference compared to traditional silicone gel sheets
- Steroid-free formulation to minimize potential side effects